MA18.11 A Phase Ib/II Study of Senaparib in Combination with Low-dose Temozolomide: Updated Results in Relapsed ES-SCLC Patients
Autor: | Hong, M.H., Gao, B., Cheng, Y., Shim, B.-Y., Johnson, M., Liu, C.-Y., Kim, S.-W., Lee, K.H., Zielinski, R., Eek, R., Hu, S., Lin, C.-C., Chung, W.-P., Hsieh, C.-Y., Cai, S.X., Tian, Y.E., Liu, L., Niu, T., Halcro, C., Li, B., Zhang, M., Zhang, C., Li, H., Xu, L., Hung, H.T. |
---|---|
Zdroj: | Journal of Thoracic Oncology; November 2023, Vol. 18 Issue: 11, Number 11 Supplement 1 pS169-S170, 2p |
Databáze: | Supplemental Index |
Externí odkaz: |